LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals (Nasdaq: EPIX), announced today that Andrew Uprichard, M.D., president and head of research and development of EPIX, will participate in a focus session entitled “The Future of Obesity: Drugs and Devices on the Horizon” at The Neurotech Industry Investing & Partnering Conference at the Westin San Francisco Airport, Millbrae, California, on Friday, May 18, 2007 at 9:15 a.m. (PDT).
